Article PDF
References
Hardy J-F, Bélisle S, Robitaille D. Blood products: when to use them and how to avoid them. Can J Anaesth 1994; 41: R52–61.
Goodnough LT, Johnston MFM, Toy PTCY, The Transfusion Medicine Academic Award Group. The variability of transfusion practice in coronary artery bypass surgery. JAMA 1991; 265: 86–90.
Forbes JM, Anderson MD, Anderson GF, Bleecker GC, Rossi EC, Moss GS. Blood transfusion costs: a multicenter study. Transfusion 1991; 31: 318–23.
Anonymous. Clinical Guide to Transfusion, 3rd Edition. The Canadian Red Cross Society: 1993.
Spiess BD. Hemorrhage, coagulation, and transfusion: a risk-benefit analysis. J Cardiothorac Vasc Anesth 1994; 8(Suppl 1): 19–22.
Kruskall MS, Glazer EE, Leonard SS, et al. Utilization and effectiveness of a hospital autologous preoperative blood donor program. Transfusion 1986; 26: 335–40.
Britton LW, Eastlund DT, Dziuban SW, et al. Predonated autologue blood use in elective cardiac surgery. Ann Thorac Surg 1989; 47: 529–32.
Owings DV, Kruskall MS, Thurer RL, Donoval LM. Autologous blood donations prior to elective cardiac surgery. Safety and effect on subsequent blood use. JAMA 1989; 262: 1963–8.
Chambers LA, Kruskall MS. Preoperative autologous blood donation. Transfusion Medicine Reviews 1990; 4: 35–46.
Spiess BD, Sassetti R, McCarthy RJ, Narbone RF, Turnan KJ, Ivankovich AC. Autologous blood donation: hemodynamics in a high-risk patient population. Transfusion 1992; 32: 17–22.
Love TR, Hendren WG, O’Keefe DD, Daggett WM. Transfusion of predonated autologous blood in elective cardiac surgery. Ann Thorac Surg 1987; 43: 508–12.
Mann M, Sacks HJ, Goldfinger D. Safety of autologous blood donation prior to elective surgery for a variety of potentially “high-risk” patients. Transfusion 1983; 23: 229–32.
Pinkerton PH. Autologous blood donation in support of cardiac surgery: a preliminary report on a hospital-based autologous donor program. Can J Anaesth 1994; 41: 1036–40.
Hardy J-F, Perrault J, Tremblay N, Robitaille D, Blain R, Carrier M. The stratification of cardiac surgical procedures according to use of blood products: a retrospective analysis of 1480 cases. Can J Anaesth 1991; 38: 511–7.
Axelrod FB, Pepkowitz SH, Goldfinger D. Establishment of a schedule of optimal preoperative collection of autologous blood. Transfusion 1989; 29: 677–80.
Goodnough LT, Rudnick S, Price TH, et al. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. N Engl J Med 1989; 321: 1163–8.
Kyo S, Omoto R, Hiroshima K, Eguchi S, Fujita T. Effect of human recombinant erythropoietin on reduction of homologous blood transfusion in open-heart surgery. Circulation 1992; 86(Suppl II): II–413-8.
Nonoguchi H, Abe K, Komatsu F. Recombinant human erythropoietin for autologous blood donation (Letter). Lancet 1992; 339: 1483.
Goodnough LT, Johnston MFM, Ramsey G, et al. Guidelines for transfusion support in patients undergoing coronary artery bypass grafting. Ann Thorac Surg 1990; 50: 675–83.
Dzik WH, Devarajan S. Should autologous blood that tests positive for infectious diseases be used or discarded? A decision analysis approach. Transfusion 1989; 29: 743–45.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hardy, JF., Bélisle, S. & Décary, F. Cardiac surgical patients must not be denied the benefits of autologous blood predonation. Can J Anaesth 41, 1021–1026 (1994). https://doi.org/10.1007/BF03015647
Issue Date:
DOI: https://doi.org/10.1007/BF03015647